Ert and cognitive decline

Journal of the American Geriatrics Society

Volumn 48, Issue 3, 2000, Pages 345-346

  Cunningham, C ^a   O'Neill, D ^a   Rowan, M ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN;

AGING; ALZHEIMER DISEASE; COGNITIVE DEFECT; DEMENTIA; ESTROGEN THERAPY; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; LETTER; MAJOR CLINICAL STUDY; POSTMENOPAUSE; TREATMENT OUTCOME;

AGING; COGNITION; COGNITION DISORDERS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS;

EID: 0034073774     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2000.tb02663.x     Document Type: Letter

References (6)

1. Matthews K., Cauley J., Yaffe K., Zmuda JM,. Estrogen replacement therapy and cognitive decline in older community women. J Am Geriatr Soc 1999; 47: 518-523.
2. Bachman DL, Wolf PA, Linn RT, et al,. Incidence of dementia and probable Alzheimer's disease in a general population: The Framingham Study. Neurology 1993; 43: 515-519.
3. Tang MX, Jacobs D., Stern Y., et al,. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996; 348: 429-432.
4. Kawas C., Resnick S., Morrison A., et al,. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging. Neurology 1997; 48: 1517-1521. [published erratum appears in Neurology 1998; 51: 654].
5. Barrett-Connor E., Kritz-Silverstein D.,. Estrogen replacement therapy and cognitive function in older women. JAMA 1993; 269: 2637-2641.
6. Szklo M., Cerhan J., Diez-Roux AV, et al,. Estrogen replacement therapy and cognitive functioning in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 1996; 144: 1048-1057.